Cafepharma Today

April 23 2024 - Sanofi gears up for approval of its BTK inhibitor, meets Phase III endpoint
Sanofi gears up for approval of its BTK inhibitor, meets Phase III endpoint
Big Pharma market caps surge to start 2024 despite economic headwinds
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
Novartis names ex-BMS CEO Caforio as chair amid strong Q1
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biotech naming trends bypass 'buzzwords and business speak' to build whimsical, memorable brands
Fierce Biotech
Tuesday, April 16, 2024 - 10:13pm
tags:
biotech, branding
US to see surge in new obesity drug launches in next five years
Biopharma Reporter
Tuesday, April 16, 2024 - 10:11pm
tags:
obesity, drug launches, weight loss
Takeda inks sweet $1.2B+ deal with Kumquat for immuno-oncology program
Fierce Biotech
Tuesday, April 16, 2024 - 10:10pm
tags:
Takeda, Kumquat Biosciences, biobucks, immuno-oncology
UnitedHealth cyberattack: Things won't be back to normal until 2025
Axios
Tuesday, April 16, 2024 - 10:09pm
tags:
Unitedhealth Group, cyberattack, cybersecurity, earnings
‘We think in decades’: J&J’s $30B spending spree may not be over
Medtech Dive
Tuesday, April 16, 2024 - 10:07pm
tags:
JNJ, Medtech, M&A, Abiomed, Laminar, Shockwave Medical
Arrowhead's plozasiran could reach $700M-plus in sales by 2032, meet major unmet need in dyslipidemia: GlobalData
Fierce Pharma
Tuesday, April 16, 2024 - 10:05pm
tags:
Arrowhead Pharmaceuticals, clinical trials, RNAi, plozasiran, dyslipidemia
Regeneron to defend against DOJ complaint on drug-price manipulation
Yahoo/Reuters
Tuesday, April 16, 2024 - 10:02pm
tags:
Regeneron, DOJ, drug pricing, Eylea
J&J narrowly misses Q1 revenue on lower-than-expected Stelara sales
BioSpace
Tuesday, April 16, 2024 - 11:19am
tags:
JNJ, earnings
Ukraine was pharma’s ‘darling’ of clinical trials. As war drags on, will the industry come back?
Pharma Voice
Tuesday, April 16, 2024 - 11:17am
tags:
Ukraine, clinical trials
Why are US pharmacy benefit managers under fire?
Reuters
Tuesday, April 16, 2024 - 11:14am
tags:
PBMs, congress, Cigna, Humana, CVS Health
Intra-Cellular Launches 26% To Record High, Breaking Out After Depression Drug Scores Big
Investors Business Daily
Tuesday, April 16, 2024 - 11:13am
tags:
Intra-Cellular Therapies, Caplyta, clinical trials, major depressive disorder
Biotech landlord Alexandria on research clusters and the sector’s recovery
Biopharma Dive
Tuesday, April 16, 2024 - 11:09am
tags:
Alexandria, biotech, biotech hubs
Ultragenyx says Angelman therapy is working, but safety questions remain
BioPharma Dive
Tuesday, April 16, 2024 - 7:49am
tags:
Ultragenyx, Angelman Syndrome, GTX-102
Humira biosimilar scripts take off
Axios
Tuesday, April 16, 2024 - 7:42am
tags:
AbbVie, Humira, biosimilars, CVS Health
Removing the Misconceptions Surrounding Biosimilar Interchangeability
Center for Biosimilars
Tuesday, April 16, 2024 - 7:41am
tags:
FDA, interchangeability, biosimilars
Edwards pushes back on Medtronic’s head-to-head TAVR trial
Medtech Dive
Tuesday, April 16, 2024 - 7:37am
tags:
Medtech, TAVR, clinical trials, Edwards Lifesciences, Medtronic, women
GSK trails after Pfizer in 5-in-1 meningococcal vaccine race
Pharmaphorum
Tuesday, April 16, 2024 - 7:35am
tags:
GSK, meningococcal disease, Pfizer, vaccines, FDA, Bexero, Menveo
Boehringer says R&D pipeline is the best in its long history
Pharmaphorum
Tuesday, April 16, 2024 - 7:33am
tags:
Boehinger Ingelheim, R&D
Marinus fails to meet early stopping criteria for status epilepticus trial
Clinical Trials Arena
Tuesday, April 16, 2024 - 7:32am
tags:
Marinus Pharmaceuticals, clinical trials, ganaxolone, status epilepticus
Pfizer, BioNTech win pause in patent infringement case from rival Moderna
Fierce Pharma
Monday, April 15, 2024 - 9:36pm
tags:
Pfizer, BioNTech, legal, patents, Moderna Therapeutics, MRNA, vaccines, COVID-19

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

How GoodRx is Evolving Its Reimbursement Approaches to Help Pharmacies and Consumers
Drug Channels
The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents
Drug Channels
How Patient Engagement Can Reduce Brand Launch Risks
Drug Channels
The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead
Drug Channels
SAVE THE DATE: Drug Channels Leadership Forum, March 17-19, 2025
Drug Channels
Tales of the Unsurprised: U.S. Brand-Name Drug Prices Fell for an Unprecedented Sixth Consecutive Year—And Will Fall Further in 2024 (rerun)
Drug Channels
Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies (rerun)
Drug Channels
The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup (rerun)
Drug Channels
What CVS Pharmacy’s New Cost-Plus Reimbursement Approach Means for PBMs, Pharmacies, Plan Sponsors, and Prescription Prices (rerun)
Drug Channels

Latest Jobs

Account Executive - Hospice
Kansas City, MO, 64113
Agape Care Group
Account Executive - Hospice
Buckner, MO, 64016
Agape Care Group
Account Executive - Hospice
Wellington, MO, 64097
Agape Care Group
Account Executive - Hospice
Independence, MO, 64057
Agape Care Group
Account Executive - Hospice
Kansas City, MO, 64158
Agape Care Group
Account Executive - Hospice
Kansas City, MO, 64119
Agape Care Group
Account Executive - Hospice
Raymore, MO, 64083
Agape Care Group
Account Executive - Hospice
Kansas City, MO, 64120
Agape Care Group
Account Executive - Hospice
Archie, MO, 64725
Agape Care Group
Account Executive - Hospice
Mayview, MO, 64071
Agape Care Group
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information